Search results

From Proteopedia

There is no page with the exact title "Pharm,_C". The search results for "Pharm,_C" are displayed below. You can create a page titled Pharm,_C (by clicking on the red link).

For more information about searching Proteopedia, see Help.

Showing below up to 20 results starting with #1.

Article title matches

1. Category:Pharm, C (39 bytes)
   1: List of pages with the keyword Pharm, C
2. Category:Pharm C (38 bytes)
   1: List of pages with the keyword Pharm C

Page text matches

1. 1bmq (4,963 bytes)
   16: ...nitial_scene = true; script "/wiki/ConSurf/bm/1bmq_consurf.spt"</scriptWhenChecked>
   20: ...l data available from [http://bental.tau.ac.il/new_ConSurfDB/main_output.php?pdb_ID=1bmq ConSurf].
   26: ... Terai Y, Takeuchi M, Shibanuma T, Isomura Y Chem Pharm Bull (Tokyo). 1999 Jan;47(1):11-21. PMID:9987822<...
2. 2omg (6,681 bytes)
   18: ...nitial_scene = true; script "/wiki/ConSurf/om/2omg_consurf.spt"</scriptWhenChecked>
   22: ...l data available from [http://bental.tau.ac.il/new_ConSurfDB/main_output.php?pdb_ID=2omg ConSurf].
   26: ...e of urea, with conditions closely resembling the pharmaceutical formulation. Data from these NPH microcr...
   28: ...tions.,Norrman M, Hubalek F, Schluckebier G Eur J Pharm Sci. 2007 Apr;30(5):414-23. Epub 2007 Jan 20. PMI...
3. 2omi (6,428 bytes)
   18: ...nitial_scene = true; script "/wiki/ConSurf/om/2omi_consurf.spt"</scriptWhenChecked>
   22: ...l data available from [http://bental.tau.ac.il/new_ConSurfDB/main_output.php?pdb_ID=2omi ConSurf].
   26: ...e of urea, with conditions closely resembling the pharmaceutical formulation. Data from these NPH microcr...
   28: ...tions.,Norrman M, Hubalek F, Schluckebier G Eur J Pharm Sci. 2007 Apr;30(5):414-23. Epub 2007 Jan 20. PMI...
4. 1it9 (4,655 bytes)
   13: ...nitial_scene = true; script "/wiki/ConSurf/it/1it9_consurf.spt"</scriptWhenChecked>
   17: ...l data available from [http://bental.tau.ac.il/new_ConSurfDB/main_output.php?pdb_ID=1it9 ConSurf].
   23: ...Ichikawa K, Ohsumi J, Yonehara S, Serizawa N Biol Pharm Bull. 2002 Dec;25(12):1537-45. PMID:12499636<ref>...
5. 1rch (4,294 bytes)
   5: ...ce from [https://en.wikipedia.org/wiki/Escherichia_coli Escherichia coli]. Full experimental informati...
   15: ...nitial_scene = true; script "/wiki/ConSurf/rc/1rch_consurf.spt"</scriptWhenChecked>
   19: ...l data available from [http://bental.tau.ac.il/new_ConSurfDB/main_output.php?pdb_ID=1rch ConSurf].
   25: ...M, Kato T, Yamazaki T, Yamasaki K, Nagayam K Biol Pharm Bull. 2000 Oct;23(10):1147-52. PMID:11041241<ref>...
6. 9qje (5,953 bytes)
   16: ...rhofer M, Stehle T, Gehringer M, Boeckler FM Arch Pharm (Weinheim). 2025 Aug;358(8):e70053. doi: 10.1002/...
7. 2zzu (6,177 bytes)
   18: ...nitial_scene = true; script "/wiki/ConSurf/zz/2zzu_consurf.spt"</scriptWhenChecked>
   22: ...l data available from [http://bental.tau.ac.il/new_ConSurfDB/main_output.php?pdb_ID=2zzu ConSurf].
   28: ...itazawa T, Esaki K, Ohta M, Sato H, Kozono T Chem Pharm Bull (Tokyo). 2010 Jan;58(1):38-44. PMID:20045964...
8. User:Steve Emery (54 bytes)
   1: Pharm-D student at University of Southern Nevada (USN)
9. User:Jessica Sheehe/Sandbox 1 (16,683 bytes)
   135: ...) cGMP regulated protein kinases (cGK). Handb Exp Pharmacol:137–62. A
   160: ...eptide inhibitors targeting protein kinases. Curr Pharm Des 15:2463–70.
10. Sandbox Reserved 166 (6,593 bytes)
    30: ...enzymatic properties of human serum albumin. Biol Pharm Bull 2002;25:695-704. </ref>.
11. 3b1m (6,329 bytes)
    18: ...ma R, Wakimoto S, Ogata T, Araki K, Ohsumi J Biol Pharm Bull. 2011;34(7):1094-104. PMID:21720019<ref>PMID...
12. User:David L. Nelson/Sandbox 9 (10,110 bytes)
    18: ... the <scene name='User:David_L._Nelson/Sandbox_9/B_chain/1'>B-Chain</scene> have 21 and 30 amino acids...
    20: ...ngkjoer L. Insulin structure and stability. 1993. Pharm. Biotechnol. 315–355.</ref> These two section...
13. 9lg0 (4,427 bytes)
    16: ...heng J, Shen X, Chen K, Xu H, Zhang Y, Luo C Acta Pharm Sin B. 2025 Aug;15(8):3997-4013. doi: 10.1016/j.a...
14. 4ef8 (3,484 bytes)
    14: ...ological intervention and open an opportunity for pharmaceutical innovation. In the current review, we di...
    16: ...droorotate.,Pinheiro MP, Emery FD, Nonato MC Curr Pharm Des. 2012 Oct 31. PMID:23116399<ref>PMID:23116399...
15. 4ef9 (3,499 bytes)
    14: ...ological intervention and open an opportunity for pharmaceutical innovation. In the current review, we di...
    16: ...droorotate.,Pinheiro MP, Emery FD, Nonato MC Curr Pharm Des. 2012 Oct 31. PMID:23116399<ref>PMID:23116399...
16. 4eww (5,545 bytes)
    16: ...insulin at potency of 100U/mL from four different pharmaceutical products directly from their final finis...
    18: ... LC, Souza TA, Almeida FC, Lima LM Eur J Pharm Biopharm. 2013 May 18. pii: S0939-6411(13)00173-2. doi:, 1...
17. 4ewx (5,547 bytes)
    16: ...insulin at potency of 100U/mL from four different pharmaceutical products directly from their final finis...
    18: ... LC, Souza TA, Almeida FC, Lima LM Eur J Pharm Biopharm. 2013 May 18. pii: S0939-6411(13)00173-2. doi:, 1...
18. 4ewz (5,547 bytes)
    16: ...insulin at potency of 100U/mL from four different pharmaceutical products directly from their final finis...
    18: ... LC, Souza TA, Almeida FC, Lima LM Eur J Pharm Biopharm. 2013 May 18. pii: S0939-6411(13)00173-2. doi:, 1...
19. 4ex0 (5,546 bytes)
    16: ...insulin at potency of 100U/mL from four different pharmaceutical products directly from their final finis...
    18: ... LC, Souza TA, Almeida FC, Lima LM Eur J Pharm Biopharm. 2013 May 18. pii: S0939-6411(13)00173-2. doi:, 1...
20. 4ex1 (5,547 bytes)
    16: ...insulin at potency of 100U/mL from four different pharmaceutical products directly from their final finis...
    18: ... LC, Souza TA, Almeida FC, Lima LM Eur J Pharm Biopharm. 2013 May 18. pii: S0939-6411(13)00173-2. doi:, 1...

View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)